MoonLake Immunotherapeutics (MLTX) earnings, May 10, 2026: EPS −56%, stock +10.4%
In brief
MoonLake Immunotherapeutics reported on May 10, 2026. Earnings per share changed −56% year over year, 9.9% below the estimate; revenue 0%. The stock opened with a +6.9% gap and closed the day +10.4% (May 11, 2026). The stock is now 53.6% below its 52-week high, +2.0% over 12 months. Next report: Mar 4, 2027.
EPS vs estimate−9.9%
EPS, YoY−56%
Revenue, YoY0%
Gap · day+6.9% · +10.4%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| May 10, 2026 | +6.9% | +10.4% |
Next-quarter estimates, ratings and the MLTX chart are in the terminal.
Open the terminalFAQ
When is MoonLake Immunotherapeutics's next earnings report?
Mar 4, 2027. The date comes from daily data and is corrected if the company moves it.
How did MoonLake Immunotherapeutics stock react to the report?
Opening gap +6.9%, day's result +10.4%.
Did MoonLake Immunotherapeutics's earnings grow?
Earnings per share fell 56% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.